Mackay Shields LLC Insmed Inc Transaction History

Mackay Shields LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$24.17 - $36.01 $1.15 Million - $1.72 Million	-47,744 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$32.28 - $44.3 $804,934 - $1.1 Million	-24,936 Reduced 34.31%	47,744 $1.63 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $544,085 - $701,342	-17,300 Reduced 19.23%	72,680 $2.42 Million
Q3 2020 Nov 04, 2020	SELL	$26.0 - $34.5 $88,400 - $117,300	-3,400 Reduced 3.64%	89,980 $2.89 Million
Q2 2020 Jul 31, 2020	BUY	$14.11 - $29.42 $235,637 - $491,314	16,700 Added 21.78%	93,380 $2.57 Million
Q1 2020 May 08, 2020	SELL	$13.63 - $33.98 $265,785 - $662,609	-19,500 Reduced 20.27%	76,680 $1.23 Million
Q4 2019 Feb 11, 2020	BUY	$16.12 - $24.98 $283,712 - $439,648	17,600 Added 22.4%	96,180 $2.3 Million
Q3 2019 Nov 01, 2019	BUY	$15.49 - $25.78 $192,076 - $319,672	12,400 Added 18.74%	78,580 $1.39 Million
Q2 2019 Aug 13, 2019	BUY	$23.0 - $32.19 $962,228 - $1.35 Million	41,836 Added 171.85%	66,180 $1.69 Million
Q1 2019 May 15, 2019	SELL	$13.91 - $31.15 $6.13 Million - $13.7 Million	-441,000 Reduced 94.77%	24,344 $708,000
Q1 2019 May 13, 2019	BUY	$13.91 - $31.15 $6.05 Million - $13.5 Million	434,600 Added 1413.61%	465,344 $1.16 Million
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $37,862 - $61,036	-3,264 Reduced 9.6%	30,744 $403,000
Q3 2018 Nov 14, 2018	BUY	$18.95 - $28.08 $96,645 - $143,208	5,100 Added 17.64%	34,008 $688,000
Q1 2018 May 03, 2018	BUY	$21.69 - $32.99 $627,014 - $953,674	28,908 New	28,908 $651,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.